| Literature DB >> 35196404 |
Peter Georgi1, Gustavo Kertzscher2, Lars Nyvang2, Jaroslav Šolc3, Thorsten Schneider4, Kari Tanderup1,2, Jacob Graversen Johansen1,2.
Abstract
BACKGROUND: Electronic brachytherapy (eBT) is considered a safe treatment with good outcomes. However, eBT lacks standardized and independent dose verification, which could impede future use.Entities:
Keywords: Monte Carlo dosimetry; dose verification; electronic brachytherapy; plastic scintillators
Mesh:
Substances:
Year: 2022 PMID: 35196404 PMCID: PMC9314913 DOI: 10.1002/mp.15568
Source DB: PubMed Journal: Med Phys ISSN: 0094-2405 Impact factor: 4.506
FIGURE 1(a) Sketch of the dosimeter probe. (b) Sketch and (c) picture of the setup used for dosimeter and source stability measurements. (d) Sketch and (e) picture of the experimental setup used for 3D dose distribution measurements
FIGURE 4The spectrum of a P50 eBT source as measured in air at a 25 cm distance (solid line) and gained from Monte Carlo simulation (dotted line)
FIGURE 2The relative output dose rate of the P50 as measured with (a) the PSD and (b) with the WTCh during 6 irradiations. Each of the six measurements is plotted with distinct symbols. All measurements are normalized to the mean value (the dashed line is an exponential fit to the mean of the six normalized measurements). (c) The deviation between the normalized WTCh and PSD measurements
FIGURE 3a) The relative response of the PSD as a function of dose rate (squares). Error bars indicate ±1 SD. The data are normalized to the measurements taken at a tube current of 1.5 mA in P50. b) The ratio of Monte Carlo scored dose to water and polystyrene as a function of depth in water when exposed to the P50 spectrum (squares). Data are normalized to a depth of 20 mm. Error bars indicate ±1 SD. In both figures, the dashed line is a linear fit to the measurements.
FIGURE 5Histogram of the measured phantom stage step‐size when expecting 1 mm steps along the three axes of movement. The SD along each axis is denoted with dotted lines, and the mean step size is denoted with dashed lines
FIGURE 6(a) PDD curve as measured with the PSD (diamonds) and scored with Monte Carlo simulation (squares). The dashed line is a linear interpolation of the MC results. Error bars indicate ±1 SD. (b) The ratio between the measured and scored doses (dots). Error bars indicate ±1 SD. Lines denote 0% (dashed) and 1% (dotted) deviations
FIGURE 7Dose profiles as measured along the x‐axis (crosses) and y‐axis (circles) and scored with MC simulation (solid line). Figure f) shows the FWHM of the profiles (dots) as a function of depth along with linear fits (dashed line along x‐axis measurements, dotted line along y‐axis measurements, and dotted‐dashed line for MC results)
Estimated uncertainty contribution to the relative dose as measured with the PSD and scored with MC from each component
| Term | Description | Relative uncertainty contribution, σ (%) |
|---|---|---|
|
| ||
|
| The raw signal from the PSD, for which the uncertainty is determined from the stability measurements | 1.3 |
|
| Dose‐rate response linearity factor | 1.7 |
|
| Normalization factor for stem‐effect in PSD and BF probe | 0.4 |
|
| The raw signal from the BF probe, from which the uncertainty is determined from the above factor | 0.4 |
|
| The background signal when measuring with PSD. Undetectable in current setup, and therefore set to the minimally detectable value | 0.5 |
|
| The background signal when measuring with the BF probe. Undetectable in current setup, and therefore set to the minimally detectable value | 0.5 |
|
| The energy‐correction factor | 0.8 |
|
| The relative position between the source and detector | ± 0.2 mm |
|
|
|
|
|
| ||
|
| The statistical uncertainty based on the number of simulations performed, see also figure 1S in the supplementary material | 1.2 |
|
| The uncertainty stemming from uncertainty in the P50 potential and hence the energy spectrum, Figure | 3.5 |
|
|
|
|